You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company said that the difference in share capital resulting from the reduction would be credited to the capital reserve, and "would serve in the full amount to offset depreciation and cover other losses."
After the split, the Norwegian firm had about 27 million shares of common stock outstanding.
MDRNA, now known as Marina Biotech, plans a 1-for-4 reverse stock split, which will enable it to have enough authorized shares to consummate the acquisition of Cequent.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.
Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.
According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.
In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.